CAS No. 1392136-43-4
Batch:
Purity:99.86
Chemical Structure
Check the
Verdinexor (KPT-335)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyridin-2-ylprop-2-enehydrazide | |
|---|---|---|
| CAS Number | 1392136-43-4 | |
| Molecular Formula |
C18H12F6N6O |
|
| Molecular Weight (MW) | 442.32 | |
| SMILES | C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F | |
| InChIKey | OPAKEJZFFCECPN-XQRVVYSFSA-N |
Verdinexor (KPT-335) is an orally bioavailable, selective inhibitor of exportin-1 (XPO1/CRM1). By blocking XPO1-mediated nuclear export, Verdinexor forces the nuclear retention of tumor suppressor proteins and signaling factors, disrupting critical oncogenic and viral replication pathways. This targeted inhibition suppresses cell proliferation, attenuates viral load, and induces apoptosis across preclinical models of hematologic malignancies and viral infections. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
88 mg/mL
(198.95 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 2 mg/mL |
| Water | Insoluble |
| DMSO |
88 mg/mL
(198.95 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 11 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Verdinexor (KPT-335) Clinical Trials
- Verdinexor (KPT-335) Solubility in DMSO
- Verdinexor (KPT-335) Stock Solution
- Verdinexor (KPT-335) Storage
- Verdinexor (KPT-335) Stability
- Verdinexor (KPT-335) Molecular Weight
- Verdinexor (KPT-335) SMILES
- Verdinexor (KPT-335) Chemical Structure (2D and 3D)
- Verdinexor (KPT-335) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.